Fig. 1From: Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort studyFlow diagram for patient selection. AKI, acute kidney injury; CFPM, cefepime; PIPC/TAZ, piperacillin/tazobactam; RRT, renal replacement therapy; VCM, vancomycinBack to article page